Evidence map›Paper›PMID 30174301›Full record

ReviewDNA repair2018

Molecular basis for damage recognition and verification by XPC-RAD23B and TFIIH in nucleotide excision repair.

Hong Mu, Nicholas E Geacintov, Suse Broyde, Jung-Eun Yeo, Orlando D Schärer

Open access · greenAbstract readReview
In one paragraph

Review in DNA repair, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 69 citations in OpenAlex.

  1. DNA Repair Mechanisms.Methods in molecular biology (Clifton, N.J.) · 2027
    Review
  2. Article
  3. Article
  4. Article
  5. The aflatoxin BNAR cancer · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. XPG: a multitasking genome caretaker.Cellular and molecular life sciences : CMLS · 2022
    Review
  19. Therapeutic Targeting of DNA Damage Response in Cancer.International journal of molecular sciences · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Hong MuDepartment of Biology, New York University, New York, NY 10003, USA.
Nicholas E GeacintovDepartment of Chemistry, New York University, New York, NY 10003, USA.
Suse BroydeDepartment of Biology, New York University, New York, NY 10003, USA.
Jung-Eun YeoCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Republic of Korea.
Orlando D SchärerCenter for Genomic Integrity, Institute for Basic Science, Ulsan, Republic of Korea; Department of Biological Sciences, School of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea. Electronic address: orlando.scharer@ibs.re.kr.
New York University · USInstitute for Basic Science · KRUlsan National Institute of Science and Technology · KR

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI John A. Tainer · 2001 to 2026
$89.6M
MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
DNA Lesion Structures: Mutagenicity and RepairR01CA075449 · NCI · NEW YORK UNIVERSITY · PI BROYDE, SUSE · 1997 to 2015
$4.3M
Environmental DNA Lesions and Mutagenesis: Molecular Mechanisms of Lesion Recognition for Repair and Polymerase BypassR01ES025987 · NIEHS · NEW YORK UNIVERSITY · PI BROYDE, SUSE · 2016 to 2025
$3.6M
The XPA scaffold protein in Nucleotide Excision RepairR01CA218315 · NCI · VANDERBILT UNIVERSITY · PI WALTER J. CHAZIN · 2018 to 2026
$3.4M
Recognition of Environmental Carcinogen-DNA lesions by NER ProteinsR01ES024050 · NIEHS · NEW YORK UNIVERSITY · PI GEACINTOV, NICHOLAS E · 2014 to 2018
$1.8M
NCI NIH HHS P01 CA092584NCI NIH HHS R01 CA075449NCI NIH HHS R01 CA218315NIEHS NIH HHS R01 ES024050NIEHS NIH HHS R01 ES025987NIGMS NIH HHS T32 GM008320
6 · The paper itself

Abstract

Global genome nucleotide excision repair (GG-NER) is the main pathway for the removal of bulky lesions from DNA and is characterized by an extraordinarily wide substrate specificity. Remarkably, the efficiency of lesion removal varies dramatically and certain lesions escape repair altogether and are therefore associated with high levels of mutagenicity. Central to the multistep mechanism of damage recognition in NER is the sensing of lesion-induced thermodynamic and structural alterations of DNA by the XPC-RAD23B protein and the verification of the damage by the transcription/repair factor TFIIH. Additional factors contribute to the process: UV-DDB, for the recognition of certain UV-induced lesions in particular in the context of chromatin, while the XPA protein is believed to have a role in damage verification and NER complex assembly. Here we consider the molecular mechanisms that determine repair efficiency in GG-NER based on recent structural, computational, biochemical, cellular and single molecule studies of XPC-RAD23B and its yeast ortholog Rad4. We discuss how the actions of XPC-RAD23B are integrated with those of other NER proteins and, based on recent high-resolution structures of TFIIH, present a structural model of how XPC-RAD23B and TFIIH cooperate in damage recognition and verification.

Indexed as

DNA DamageDNA RepairDNADNA AdductsDNA-Binding ProteinsDNA Repair EnzymesHumansTranscription Factor TFIIHYeastsDNADNA AdductsDNA-Binding ProteinsDNA Repair EnzymesRAD23B protein, humanTranscription Factor TFIIHXPC protein, humanDNA damage recognitionMolecular dynamics simulationsNucleotide excision repairTFIIHUV-DDBXPC-RAD23B

Identifiers

PMID30174301
PMCPMC6340764
OpenAlexW2888475364

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.